Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

Clicks: 518
ID: 114518
2002
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #21 of 183 articles by views in The New England journal of medicine

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 183 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Voriconazole is a suitable alternative to amphotericin B preparations for empirical antifungal therapy in patients with neutropenia and persistent fever.
Reference Key
tj2002thevoriconazole Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Walsh TJ;Pappas P;Winston DJ;Lazarus HM;Petersen F;Raffalli J;Yanovich S;Stiff P;Greenberg R;Donowitz G;Schuster M;Reboli A;Wingard J;Arndt C;Reinhardt J;Hadley S;Finberg R;Laverdière M;Perfect J;Garber G;Fioritoni G;Anaissie E;Lee J; ;;
Journal The New England journal of medicine
Year 2002
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/11807146
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't adult female male adolescent aged middle aged Child Comparative Study Prospective Studies P.H.S. 80 and over Clinical Trial Randomized Controlled Trial Multicenter Study anti-bacterial agents / therapeutic use intravenous / adverse effects fever / drug therapy* neutropenia / drug therapy* fever / etiology neutropenia / etiology chronic disease mycoses / prevention & control* neoplasms / complications antifungal agents / adverse effects pyrimidines / adverse effects triazoles / adverse effects voriconazole infusions neoplasms / therapy pmid:11807146 doi:10.1056/nejm200201243460403 thomas j walsh peter pappas national institute of allergy and infectious diseases mycoses study group amphotericin b / therapeutic use* antifungal agents / pharmacokinetics antifungal agents / therapeutic use* chemical and drug induced liver injury pyrimidines / pharmacokinetics pyrimidines / therapeutic use* triazoles / pharmacokinetics triazoles / therapeutic use*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.